The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis ...

At Mercy, they currently offer several procedures to treat AFib, but now they’re the first in the region to use new ...

KY3's Chris Bryant reports.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced ...

Afib Manager is currently only available to Apple users. This free tool works by integrating with Apple’s Health app on an iPhone or Apple Watch to monitor your heart rate data. Moreover, the app will ...

As she awaited a heart ablation to treat her AFib, Dolores Catania turned to food for comfort. After her procedure, she ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

US FDA accepts for review Milestone Pharma’s response to CRL for Cardamyst nasal spray: Montreal Monday, July 14, 2025, 11:00 Hrs [IST] Milestone Pharmaceuticals Inc., a biophar ...

AtriCure (Nasdaq: ATRC) today announced the completion of enrollment in a study evaluating its AtriClip system for preventing ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...